Catalyst Wire Dossier Catalyst Wire Dossier

Bimatoprost Implant System

bimatoprost · SpyGlass Pharma, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Bimatoprost Implant System, covering 2025-08-22 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine) [Phase 3]

See pricing